| Compared with placebo, immune-enhancing Thymosin α1 treatment did not reduce the incidence of infected pancreatic necrosis in patients with predicted severe acute necrotising pancreatitis. However, it might be effective in specific subgroups of acute necrotising pancreatitis, like patients with extended pancreatic necrosis. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.